WVU Rockefeller Neuroscience Institute hosted key stakeholders from the WV Parkinson's Disease Registry Data working group like michaeljfox.org, @CAMCHealth, Marshall University , and @theWVHI this week to advance the development of a WV-wide registry to capture data with the goal of advancing patient care and research

Thank you, Garni Barkhoudarian, MD and CNS for helping share the innovation occurring in #neurosurgery and our work focused on treatment for addiction at the WVU Rockefeller Neuroscience Institute

Great meeting on the Bosphorus…

Thank you, Dr. Bob Carter, for being visiting the WVU Rockefeller Neuroscience Institute and presenting your innovative work with iPSC Derived Dopaminergic Progenitors for treatment of #ParkinsonsDisease

Met so many wonderful individuals during a Grand Rounds weekend visit to WVU Rockefeller Neuroscience Institute. @wvumedicine has built a model integrated neuroscience community and is delivering top notch neurological care to the entire state of West Virginia with cutting edge clinical trials and a newly

To boldly go… Pioneering work at the WVU Rockefeller Institute WVU Rockefeller Neuroscience Institute Ali Rezai, MD Clay Marsh, MD nejm.org/doi/full/10.10…

Thank you to @NIHendaddiction and NIDAnews for the recognition of our team with the 2024 NIH HEAL Excellence in Research Award

Population-based estimates suggest middle meningeal artery embolization for subdural hematomas could significantly expand the scope of neurovascular therapies jnis.bmj.com/content/early/…

jnis.bmj.com/content/early/…

Last stop of #OxHB US tour - West Virginia🇺🇸 🙏Prof ANSAAR RAI & team for the warm welcome! Great to learn about WVU Rockefeller Neuroscience Institute's groundbreaking work🚀 Prof Rai is author of 2023 JNIS paper on PreSize, so naturally lots of discussion on clinical evidence🧠 jnis.bmj.com/content/early/…

Another patient enrolled in the SEAL IT ANEURYSM TRIAL. What a great case and amazing pictures by Dr. SoHyun Boo at West Virginia University. These images show great conformity of the SEAL device within the aneurysm sac.

Excited to present the MEMBRANE RCT results at SVIN conference in San Diego! We evaluated TruFill n-BCA for MMA embolization in treating chronic subdural hematoma. Hope to see you there! #SVIN24 Dr. Christopher Kellner Johnson & Johnson MedTech | Neurovascular

Three become four - the MEMBRANE trial, presented by ANSAAR RAI at #SVIN24, becomes the latest large-scale RCT to demonstrate benefits with MMA embolisation over standard care in cSDH patients SVIN Dr. Christopher Kellner Johnson & Johnson MedTech | Neurovascular

Thrilled to see the presentation of the MEMBRANE Trial results by ANSAAR RAI at #SVIN24! The trial highlights the effectiveness of middle meningeal artery embolization (MMAE) as a safe, minimally invasive treatment for chronic subdural hematoma (cSDH). With promising

The MEMBRANE randomized clinical trial demonstrated a significant treatment effect favoring MMAE with Tru-Fill nBCA over standard management alone for chronic subdural hematomas. The odds ratio favored MMAE in both the surgical and non-surgical cohorts. Reduced rebleeding, higher

MEMBRANE becomes latest RCT to demonstrate MMA embolisation’s benefits in cSDH treatment neuronewsinternational.com/membrane-becom…

Great to host the J&J Med Tech NV team at the Rockefeller Neuroscience Institute WVU Rockefeller Neuroscience Institute for an immersive Tru-Fill nBCA experience. Johnson & Johnson MedTech | Neurovascular

Rising tide of middle meningeal artery embolization for chronic subdural hematomas: current volumes and future growth compared with cerebral aneurysm and stroke interventions jnis.bmj.com/content/early/…

Transverse venous sinus stenting versus cerebrospinal fluid shunting in idiopathic intracranial hypertension: a multi-institutional and multinational database study jnis.bmj.com/content/early/…